Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ItalyStudy of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
ItalyStudy of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment
ItalyStudy of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia
ItalyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer
ItalyStudy of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer
ItalyStudy Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma
ItalyStudy on the Safety and Effectiveness of Crinecerfont for Children with Classic Congenital Adrenal Hyperplasia
ItalyStudy of Pegcetacoplan (APL-2) in Patients with Transplant-associated Thrombotic Microangiopathy After Stem Cell Transplantation
ItalyStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
ItalyStudy on Carbetocin Nasal Spray for Reducing Uncontrollable Hunger in Patients with Prader-Willi Syndrome
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
